Race/ethnic and sex differences in the initiation of non-statin lipid-lowering medication following myocardial infarction
Calvin L. Colvin, Bharat Poudel, Adam P. Bress, Catherine G. Derington, Jordan B. King, Ying Wen, Ligong Chen, Vera Bittner, Todd M. Brown, Keri L. Monda, Katherine E. Mues, Robert S. Rosenson, Elizabeth A. Jackson, Paul Muntner, Lisandro D. Colantonio
Topics & Concepts
EzetimibeMedicinePCSK9Hazard ratioInternal medicineStatinMyocardial infarctionConfidence intervalCardiologyCholesterolLipoproteinLDL receptorLipoproteins and Cardiovascular HealthAntiplatelet Therapy and Cardiovascular DiseasesMedication Adherence and Compliance